Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.7T | 3.5T | 3.5T | 3.5T |
Cost of revenue | 1.1T | 984.0B | 977.2B | 989.4B |
Gross profit | 2.7T | 2.5T | 2.5T | 2.5T |
Operating expense | ||||
Research & development | 573.0B | 492.7B | 510.4B | 509.0B |
Selling general and admin | 1.3T | 1.1T | 1.2T | 1.1T |
Other operating expenses | 117.0B | 110.2B | 118.4B | 121.1B |
Operating income | 658.7B | 838.4B | 739.0B | 809.8B |
Non operating interest income | ||||
Income | 87.1B | 104.8B | 103.4B | 98.0B |
Expense | 84.4B | 83.0B | 88.5B | 85.7B |
Other income expense | -12.2B | 2.7B | 85.7B | 262.7B |
Pretax income | 649.2B | 862.9B | 839.7B | 1.1T |
Tax provision | 147.0B | 175.6B | -85.7B | 219.1B |
Net income | 500.8B | 684.6B | 924.1B | 862.9B |
Basic EPS | 0.8 | 1.1 | 1.4 | 1.3 |
Diluted EPS | 0.8 | 1.1 | 1.4 | 1.3 |
Basic average shares | 627.4B | 635.6B | 649.2B | 662.8B |
Diluted average shares | 639.7B | 646.5B | 660.1B | 672.3B |
EBITDA | 891.5B | 1.1T | 950.0B | 1.0T |
Net income from continuing op. | 502.2B | 687.3B | 925.5B | 865.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |